SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: erickerickson who wrote (63249)9/15/2025 3:53:19 PM
From: Olecranon   of 63276
 
I sold half my GLUE position. This looks like a great new arrangement, but the vast majority of the money is far out and contingent on milestone delivery. I don’t believe the market has the patience to hold this price, especially in light of a generally disfavored biotech environment and a bull market that is overextended and vulnerable to large corrections in response to headlines like the upcoming government funding deadline (end of this month).

I’m looking to add more at lower prices, ideally at or below my average price per share of $4.20.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News